Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Trends in pediatric psoriasis outpatient health care delivery in the United States.

Vogel SA, Yentzer B, Davis SA, Feldman SR, Cordoro KM.

Arch Dermatol. 2012 Jan;148(1):66-71. doi: 10.1001/archdermatol.2011.263.

PMID:
21931013
2.

Trends in older adult psoriasis outpatient health care practices in the United States.

Wong JW, Davis SA, Feldman SR, Koo JY.

J Drugs Dermatol. 2012 Aug;11(8):957-62.

PMID:
22859241
3.
4.

Patterns of vitamin D analog use for the treatment of psoriasis.

Ahn CS, Awadalla F, Huang KE, Yentzer B, Dabade TS, Feldman SR.

J Drugs Dermatol. 2013 Aug;12(8):906-10.

PMID:
23986164
5.

Which physicians are providing health care to America's children? Trends and changes during the past 20 years.

Freed GL, Nahra TA, Wheeler JR.

Arch Pediatr Adolesc Med. 2004 Jan;158(1):22-6.

PMID:
14706953
6.

Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.

Balkrishnan R, Camacho FT, Pearce DJ, Kulkarni AS, Spencer L, Fleischer AB Jr, Feldman SR.

J Drugs Dermatol. 2005 Nov-Dec;4(6):699-706.

PMID:
16302555
7.

Psoriasis treatment in the United States at the end of the 20th century.

Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB Jr, Feldman SR.

Int J Dermatol. 2006 Apr;45(4):370-4.

PMID:
16650160
8.
9.

National Ambulatory Medical Care Survey: 2001 summary.

Cherry DK, Burt CW, Woodwell DA.

Adv Data. 2003 Aug 11;(337):1-44.

PMID:
12924075
10.
11.

Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.

Rushton JL, Clark SJ, Freed GL.

Pediatrics. 2000 Jun;105(6):E82.

PMID:
10835095
12.

Increasing use of more potent treatments for psoriasis.

Strowd LC, Yentzer BA, Fleischer AB Jr, Feldman SR.

J Am Acad Dermatol. 2009 Mar;60(3):478-81. doi: 10.1016/j.jaad.2008.10.055.

PMID:
19058875
13.
14.

Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists.

Efron D, Hiscock H, Sewell JR, Cranswick NE, Vance AL, Tyl Y, Luk ES.

Pediatrics. 2003 Feb;111(2):372-5.

PMID:
12563066
15.

Medication management of stimulants in pediatric practice settings: a national perspective.

Hoagwood K, Jensen PS, Feil M, Vitiello B, Bhatara VS.

J Dev Behav Pediatr. 2000 Oct;21(5):322-31.

PMID:
11064959
16.

Utilization of physician offices by adolescents in the United States.

Ziv A, Boulet JR, Slap GB.

Pediatrics. 1999 Jul;104(1 Pt 1):35-42.

PMID:
10390257
17.

National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

Olfson M, Blanco C, Liu L, Moreno C, Laje G.

Arch Gen Psychiatry. 2006 Jun;63(6):679-85.

PMID:
16754841
19.

Identification, evaluation, and management of obesity in an academic primary care center.

O'Brien SH, Holubkov R, Reis EC.

Pediatrics. 2004 Aug;114(2):e154-9.

PMID:
15286251
20.

Trends in on and off-label calcipotriene use.

Pearce DJ, Camacho F, Balkrishnan R, Fleischer AB Jr, Feldman SR.

J Dermatolog Treat. 2006;17(5):308-13.

PMID:
17092863
Items per page

Supplemental Content

Support Center